<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The present study was carried out to elucidate the neuroprotective effect and influence of <z:chebi fb="0" ids="27881">resveratrol</z:chebi> on the extracellular levels of neurotransmitter and neuromodulator during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion in rats </plain></SENT>
<SENT sid="1" pm="."><plain>Male rats were divided into three groups: sham operation, <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> treatment, and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> combined with <z:chebi fb="0" ids="27881">resveratrol</z:chebi> treatment (<z:chebi fb="0" ids="27881">resveratrol</z:chebi>-treated group, 30 mg/kg intraperitoneally for 7 days) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo> was induced by using the model of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The dialysates in hypothalamus were obtained by brain microdialysis technique </plain></SENT>
<SENT sid="4" pm="."><plain>The levels of sixteen amino acids and <z:chebi fb="39" ids="32952">amines</z:chebi> in microdialysate were monitored by capillary electrophoresis analysis </plain></SENT>
<SENT sid="5" pm="."><plain>This study shows that the ischemic <z:mpath ids='MPATH_124'>infarcts</z:mpath> were significantly reduced and neurological functions were improved in <z:chebi fb="0" ids="27881">resveratrol</z:chebi>-treated group compared to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> group </plain></SENT>
<SENT sid="6" pm="."><plain>The analysis results demonstrate that <z:hpo ids='HP_0011010'>chronic</z:hpo> treatment with <z:chebi fb="0" ids="27881">resveratrol</z:chebi> remarkably reduced the release of excitatory neurotransmitter <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>, <z:chebi fb="0" ids="29995">aspartate</z:chebi> and neuromodulator d-Serine during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and reperfusion; and significantly increased the basal extracellular levels of inhibitory neurotransmitter <z:chebi fb="0" ids="16865">gamma-amino-n-butyric acid</z:chebi>, glycine and <z:chebi fb="5" ids="15891">taurine</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> treatment with <z:chebi fb="0" ids="27881">resveratrol</z:chebi> also ameliorated <z:chebi fb="0" ids="17553">O-phosphoethanolamine</z:chebi> levels and excitotoxic index during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and reperfusion </plain></SENT>
<SENT sid="8" pm="."><plain>This study provides the first in vivo evidence that <z:chebi fb="0" ids="27881">resveratrol</z:chebi> could exert neuroprotective effect against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> injury by modulating the release of multiple <z:chebi fb="65" ids="25512">neurotransmitters</z:chebi> and neuromodulators during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion </plain></SENT>
</text></document>